Cargando…
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics
BACKGROUND: Second-generation antipsychotics (SGAs) are assumed to have little abuse potential. However, reports of quetiapine abuse have emerged as prescribing has increased in recent years. The US Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) provides postmarketing in...
Autores principales: | Evoy, Kirk E, Teng, Chengwen, Encarnacion, Victor G, Frescas, Brian, Hakim, John, Saklad, Stephen, Frei, Christopher R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495438/ https://www.ncbi.nlm.nih.gov/pubmed/31068753 http://dx.doi.org/10.1177/1178221819844205 |
Ejemplares similares
-
2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
por: Groff, Lindsey, et al.
Publicado: (2018) -
Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)
por: Mattson, Margaret E, et al.
Publicado: (2015) -
Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
por: Klein, Lauren, et al.
Publicado: (2017) -
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
por: Teng, Chengwen, et al.
Publicado: (2021) -
Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior?
por: Kim, Sean, et al.
Publicado: (2017)